Junxia Gu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- Heat shock proteins research
- RNA Research and Splicing
- RNA modifications and cancer
Papers in
-
- Bone Metabolism and Diseases 6
- Cancer-related gene regulation 5
- RNA Research and Splicing 4
- TGF-β signaling in diseases 4
- RNA modifications and cancer 4
- FOXO transcription factor regulation 3
- Oncology 12
- Cancer-related Molecular Pathways 5
- Co-authors
- Qiping Zheng (28 shared papers)Yaojuan Lu (26 shared papers)Longwei Qiao (12 shared papers)Yuting Liang (7 shared papers)Xiaoxia Hu (6 shared papers)Na Li (3 shared papers)Qian Wang (3 shared papers)Xingang Li (3 shared papers)
- Journals
- Frontiers in Genetics (1 paper)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Gene (1 paper)npj Climate and Atmospheric Science (1 paper)Bioscience Reports (1 paper)
- Partner nations
- ChinaUnited StatesUnited Arab Emirates
In The Last Decade
Junxia Gu
35 papers receiving 410 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 83
- Molecular Biology 231
- Rheumatology 46
- Molecular Medicine 14
- Oncology 65
Countries citing papers authored by Junxia Gu
This map shows the geographic impact of Junxia Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxia Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxia Gu more than expected).
Fields of papers citing papers by Junxia Gu
This network shows the impact of papers produced by Junxia Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxia Gu. The network helps show where Junxia Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junxia Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 34 | |
| 2 | 2011 | 28 | |
| 3 | URI expression in cervical cancer cells is associated with higher invasion capacity and resistance to cisplatin. | 2015 | 26 |
| 4 | 2019 | 22 | |
| 5 | Expression analysis of URI/RMP gene in endometrioid adenocarcinoma by tissue microarray immunohistochemistry. | 2013 | 22 |
| 6 | 2017 | 20 | |
| 7 | Endothelin-A receptor antagonists in prostate cancer treatment-a meta-analysis. | 2015 | 19 |
| 8 | T-box family of transcription factor-TBX5, insights in development and disease. | 2017 | 17 |
| 9 | URI prevents potassium dichromate-induced oxidative stress and cell death in gastric cancer cells. | 2016 | 15 |
| 10 | Col10a1-Runx2 transgenic mice with delayed chondrocyte maturation are less susceptible to developing osteoarthritis. | 2014 | 15 |
| 11 | [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia]. | 2005 | 14 |
| 12 | DLX5 promotes osteosarcoma progression via activation of the NOTCH signaling pathway. | 2021 | 14 |
| 13 | 2009 | 12 | |
| 14 | Upregulation of URI/RMP gene expression in cervical cancer by high-throughput tissue microarray analysis. | 2013 | 12 |
| 15 | 2014 | 11 | |
| 16 | 2021 | 11 | |
| 17 | Hypertrophic chondrocyte-specific Col10a1 controlling elements in Cre recombinase transgenic studies. | 2019 | 11 |
| 18 | 2013 | 10 | |
| 19 | Mammalian target of rapamycin (mTOR) inhibitors and combined chemotherapy in breast cancer: a meta-analysis of randomized controlled trials. | 2014 | 10 |
| 20 | URI promotes gastric cancer cell motility, survival, and resistance to adriamycin in vitro. | 2016 | 10 |
About Junxia Gu
Junxia Gu is a scholar working on Molecular Biology, Oncology, Cancer Research, Rheumatology and Epidemiology, having authored 35 papers that have together received 410 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (6 papers), Bone Metabolism and Diseases (6 papers), Cancer-related Molecular Pathways (5 papers), Cancer-related gene regulation (5 papers), RNA Research and Splicing (4 papers), TGF-β signaling in diseases (4 papers), RNA modifications and cancer (4 papers) and FOXO transcription factor regulation (3 papers). The work is most often cited by research in Cancer Research (83 citations), Molecular Biology (231 citations), Rheumatology (46 citations), Molecular Medicine (14 citations) and Oncology (65 citations). Junxia Gu has collaborated with scholars based in China, United States and United Arab Emirates. Frequent co-authors include Qiping Zheng, Yaojuan Lu, Longwei Qiao, Yuting Liang, Xiaoxia Hu, Na Li, Qian Wang, Xingang Li, Jingcheng Miao and Jingting Jiang. Their work appears in journals such as Frontiers in Genetics, Anti-Cancer Agents in Medicinal Chemistry, Gene, npj Climate and Atmospheric Science and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.